Predicting Enrollment Performance of Investigational Centers in Phase III Multi-center Clinical Trials
Overview
Affiliations
Failure to meet subject recruitment targets in clinical trials continues to be a widespread problem with potentially serious scientific, logistical, financial and ethical consequences. On the operational level, enrollment-related issues may be mitigated by careful site selection and by allocating monitoring or training resources proportionally to the anticipated risk of poor enrollment. Such procedures require estimates of the expected recruitment performance that are sufficiently reliable to allow centers to be sensibly categorized. In this study, we investigate whether information obtained from feasibility questionnaires can potentially be used to predict which centers will and which centers will not meet their enrollment targets by means of multivariable logistic regression analysis. From a large set of 59 candidate predictors, we determined the subset that is optimal for predictive purposes using Least Absolute Shrinkage and Selection Operator (LASSO) regularization. Although the extent to which the results are generalizable remains to be determined, they indicate that the prediction accuracy of the optimal model is only a marginal improvement over the intercept-only model, illustrating the difficulty of prediction in this setting.
Enhancing site selection strategies in clinical trial recruitment using real-world data modeling.
Hulstaert L, Twick I, Sarsour K, Verstraete H PLoS One. 2024; 19(3):e0300109.
PMID: 38466688 PMC: 10927105. DOI: 10.1371/journal.pone.0300109.
McClure J, Asghar A, Krajec A, Johnson M, Subramanian S, Caroff K Contemp Clin Trials Commun. 2023; 33:101106.
PMID: 37063166 PMC: 10028341. DOI: 10.1016/j.conctc.2023.101106.
Quantifying geographical accessibility to cancer clinical trials in different income landscapes.
Tini G, Trapani D, Duso B, Beria P, Curigliano G, Pelicci P ESMO Open. 2022; 7(3):100515.
PMID: 35738201 PMC: 9271515. DOI: 10.1016/j.esmoop.2022.100515.
Laaksonen N, Bengtstrom M, Axelin A, Blomster J, Scheinin M, Huupponen R Clin Trials. 2021; 18(6):724-731.
PMID: 34431408 PMC: 8592101. DOI: 10.1177/17407745211038512.
Fogel D Contemp Clin Trials Commun. 2018; 11:156-164.
PMID: 30112460 PMC: 6092479. DOI: 10.1016/j.conctc.2018.08.001.